Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide

Molecular Medicine

Volumn 18, Issue 2, 2012, Pages 201-208

  Zhang, Lemeng ^a,b   Cardinal, Jon S ^a   Bahar, Runalia ^a   Evankovich, John ^a   Huang, Hai ^a   Nace, Gary ^a   Billiar, Timothy R ^a   Rosengart, Matthew R ^a   Pan, Pinhua ^a,b   Tsung, Allan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; LIPOPOLYSACCHARIDE; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REGULATORY MECHANISM; WILD TYPE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTOXEMIA; IN SITU NICK-END LABELING; INTERFERON REGULATORY FACTOR-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE;

EID: 84859074254     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00282     Document Type: Article

References (41)

1. Anderson RN, Smith BL. (2005) Deaths: leading causes for 2002. Natl. Vital Stat. Rep. 53:1-89.
2. Chopra M, Sharma AC. (2007) Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sci. 81:306-16.
3. Xiao H, Siddiqui J, Remick DG. (2006) Mechanisms of mortality in early and late sepsis. Infect. Immun. 74:5227-35.
4. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. (2007) Potential therapeutic applications of autophagy. Nat. Rev. Drug. Discov. 6:304-12.
5. He C, Klionsky DJ. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43:67-93.
6. Levine B, Kroemer G. (2008) Autophagy in the pathogenesis of disease. Cell. 132:27-42.
7. Sanjuan MA, et al. (2007) Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 450:1253-7.
8. Levine B, Yuan J. (2005) Autophagy in cell death: an innocent convict? J. Clin. Invest. 115:2679-88.
9. Virgin HW, Levine B. (2009) Autophagy genes in immunity. Nat. Immunol. 10:461-70.
10. Waltz P, et al. (2010) Lipopolysaccaride induces autophagic signaling in macrophages via a TLR4, heme oxygenase-1 dependent pathway. Autophagy. 7:315-20.
11. Saitoh T, et al. (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 456:264-8.
12. Hamacher-Brady A, Brady NR, Gottlieb RA. (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281:29776-87.
13. Xu Y, et al. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 27:135-44.
14. Carchman EH, Rao J, Loughran PA, Rosengart MR, Zuckerbraun BS. (2011) Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology. 53:2053-62.
15. Nakahira K, et al. (2010) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12:222-30.
16. Gonzalez-Polo RA, et al. (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 118:3091-102.
17. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. (2008) Autophagy fights disease through cellular self-digestion. Nature. 451:1069-75.
18. Levine B, Deretic V. (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7:767-77.
19. Levine B. (2005) Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 120:159-62.
20. Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP. (2002) Activities of IRF-1. J. Interferon Cytokine Res. 22:5-14.
21. Kano A, Haruyama T, Akaike T, Watanabe Y. (1999) IRF-1 is an essential mediator in IFNgamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem. Biophys. Res. Commun. 257:672-7.
22. Stang MT, et al. (2007) Interferon regulatory factor-1-induced apoptosis mediated by a ligandindependent fas-associated death domain pathway in breast cancer cells. Oncogene. 26:6420-30.
23. Papageorgiou A, Dinney CP, McConkey DJ. (2007) Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol. Ther. 6:872-9.
24. Tamura T, et al. (1995) An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogenactivated T lymphocytes. Nature. 376:596-9.
25. Senaldi G, et al. (1999) Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. J. Immunol. 163:6820-6.
26. Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies. (2011) Guide for the Care and Use of Laboratory Animals. 8th edition. Washington, (DC): National Academies Press. 220 pp. Available from: http://oacu.od.nih.gov/regs/
27. Nakamura K, Yamaji T, Crocker PR, Suzuki A, Hashimoto Y. (2002) Lymph node macrophages, but not spleen macrophages, express high levels of unmasked sialoadhesin: implication for the adhesive properties of macrophages in vivo. Glycobiology. 12:209-16.
28. Zhang C, et al. (2006) Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74:1857-64.
29. Ayala A, Urbanich MA, Herdon CD, Chaudry IH. (1996) Is sepsis-induced apoptosis associated with macrophage dysfunction? J. Trauma 40:568-73; discussion 573-4.
30. ten Hagen TL, van Vianen W, Bakker-Woudenberg IA. (1996) Isolation and characterization of murine Kupffer cells and splenic macrophages. J. Immunol. Methods 193:81-91.
31. Lederer JA. (2005) Does nitric oxide control the counter-inflammatory response in endotoxic shock? Crit. Care Med. 33:896-8.
32. Kamijo R, et al. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1612-5.
33. Gotoh T, Oyadomari S, Mori K, Mori M. (2002) Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J. Biol. Chem. 277:12343-50.
34. Hunter CJ, et al. (2009) Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect. Immun. 77:1031-43.
35. Zamora R, et al. (2005) Intestinal and hepatic expression of BNIP3 in necrotizing enterocolitis: regulation by nitric oxide and peroxynitrite. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G822-30.
36. Sarkar S, et al. (2011) Complex inhibitory effects of nitric oxide on autophagy. Mol. Cell. 43:19-32.
37. Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
38. Ziegler EJ, et al. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N. Engl. J. Med. 324:429-36.
39. Fisher CJ Jr, et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med. 334:1697-702.
40. Fisher CJ Jr, et al. (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit. Care Med. 22:12-21.
41. Haldar SM, Stamler JS. (2011) S-nitrosylation at the interface of autophagy and disease. Mol. Cell. 43:1-3.